---
title: "GUANGJI PHARMA: Net loss of 21.7836 million yuan in the third quarter"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/262761563.md"
description: "On October 26th, GUANGJI PHARMA announced that in the third quarter of 2025, it achieved operating revenue of 145 million yuan, a year-on-year decrease of 12.57%; the net loss attributable to shareholders of the listed company was 21.7836 million yuan; basic earnings per share were -0.0628 yuan"
datetime: "2025-10-26T08:56:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/262761563.md)
  - [en](https://longbridge.com/en/news/262761563.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/262761563.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/262761563.md) | [繁體中文](https://longbridge.com/zh-HK/news/262761563.md)


# GUANGJI PHARMA: Net loss of 21.7836 million yuan in the third quarter

On October 26th, GUANGJI PHARMA announced that in the third quarter of 2025, it achieved operating revenue of 145 million yuan, a year-on-year decrease of 12.57%; the net loss attributable to shareholders of the listed company was 21.7836 million yuan; basic earnings per share were -0.0628 yuan

### Related Stocks

- [GUANGJI PHARMA (000952.CN)](https://longbridge.com/en/quote/000952.CN.md)

## Related News & Research

- [Private Credit Panic Goes To 11 As World's Largest Private Credit Fund Hit With Record Redemptions](https://longbridge.com/en/news/277557900.md)
- [New study finds early hormone replacement therapy reduces risk of osteoporosis and fractures for older women](https://longbridge.com/en/news/277412093.md)
- [The chemistry of connections: Can ‘love hormones’ cure loneliness?](https://longbridge.com/en/news/277371444.md)
- [Pricing the Death of the Iranian Leader: Where Are the Ethical Boundaries of Market Prediction?](https://longbridge.com/en/news/277470377.md)
- [Prediction-market bets tied to Iran conflict stoke backlash over suspicions of insider trading](https://longbridge.com/en/news/277369538.md)